Malaria Vaccine Breakthroughs: Uganda Leads Largest Introduction, Innovative Boosters Show Promise
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Malaria Vaccine Breakthroughs: Uganda Leads Largest Introduction, Innovative Boosters Show Promise
-
ナレーター：
-
著者：
このコンテンツについて
Uganda has made a landmark move by launching the largest malaria vaccine introduction to date. As of April 2025, the R21/Matrix-M malaria vaccine, which is administered in four doses at 6, 7, 8, and 18 months, is set to target 1.1 million children under the age of two. This initiative underscores the growing commitment to utilizing vaccination as a key strategy in reducing malaria cases and fatalities[1].
Meanwhile, in the realm of research, there have been notable updates on malaria vaccine candidates. However, the latest news from the past few days does not include new breakthroughs, as the most recent significant research updates were reported earlier in the year. For instance, the FDA had paused BioNTech's phase 1/2a trial of its experimental malaria vaccine, BNT165e, in March 2025 due to unspecified concerns. This pause highlights the rigorous scrutiny and safety protocols in place for vaccine development[3].
On a more positive note, an innovative blood-stage malaria vaccine booster has shown promising results. The RH5.1/Matrix-M vaccine, which targets a different stage of the parasite life cycle compared to previously approved vaccines like RTS,S/AS01 and R21/Matrix-M, has been found to enhance immunity and reduce malaria cases. In a phase 2b clinical trial, this vaccine demonstrated 55% effectiveness in preventing clinical malaria over six months and was well tolerated with mild adverse events. This booster vaccine is seen as a complementary tool to existing vaccines, offering durable protection against malaria[4].
In Africa, countries continue to adopt and implement malaria vaccination programs. Mali, for example, has become the 20th African country to introduce the malaria vaccine, marking a significant milestone on World Malaria Day in April 2025. The introduction of the vaccine in Mali is part of broader efforts supported by UNICEF and other global health organizations to protect children from this life-threatening disease. The success of such programs is evident from the pilot evaluations of the RTS,S/AS01 vaccine in Ghana, Kenya, and Malawi, which led to a 13% reduction in mortality among vaccinated children between 2019 and 2023[5].
These developments highlight the ongoing and multifaceted approach to combating malaria, with a strong emphasis on vaccination as a critical tool in reducing the burden of this disease globally.